Wellington Shields Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Wellington Shields Capital Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-20,100	Closed	-$372K	–	346
2017 Q3	$372K	Hold	20,100	–	–	0.06%	234
2017 Q2	$340K	Hold	20,100	–	–	0.06%	256
2017 Q1	$268K	Buy	20,100 +6,000	+43%	+$94K	0.04%	271
2016 Q4	$212K	Sell	14,100 -4,500	-24%	-$59.4K	0.04%	294
2016 Q3	$217K	Buy	+18,600	New	+$219K	0.04%	287
2015 Q1	–	Sell	-50,500	Closed	-$608K	–	369
2014 Q4	$608K	Buy	50,500 +18,500	+58%	+$211K	0.1%	189
2014 Q3	$363K	Buy	32,000 +3,500	+12%	+$39.9K	0.06%	252
2014 Q2	$344K	Buy	+28,500	New	+$337K	0.05%	268

Other funds holding MNTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Wellington Shields Capital Management's MNTA Position: Q4 2017 in Review

Wellington Shields Capital Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2017, closing a stake of 20,100 shares — an estimated $372K sold.

Wellington Shields Capital Management first reported a position in MNTA in Q2 2014 and held it in 8 quarters. The position peaked at $608K in Q4 2014. 166 funds tracked by Wall St. Rank hold MNTA as of Q4 2017.

Wellington Shields Capital Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
Wellington Shields Capital Management sold 20,100 Momenta Pharmaceuticals, Inc. shares in Q4 2017, an estimated $372K.
Wellington Shields Capital Management first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2014 and held it in 8 quarters.
Wellington Shields Capital Management's Momenta Pharmaceuticals, Inc. position peaked at $608K in Q4 2014.
166 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2017.

Based on Wellington Shields Capital Management's 13F filing for Q4 2017, filed 6 Feb 2018.